Year: 2020

HANGZHOU, China, Nov. 25, 2020 (GLOBE NEWSWIRE) — In a release issued on November, 24 2020 by Yunji Inc. (NASDAQ: YJ), please note that multiple changes throughout the text have been implemented, including in the headline. The corrected release follows:Yunji Announces the Signing of a Cooperative Framework Agreement with Douyin’s E-Commerce BusinessYunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that it has signed a cooperative framework agreement (the “Agreement”) with Douyin’s E-Commerce Business. The Agreement’s establishment is in line with the Company’s strategy of exploring the live streaming potential of external platforms in such areas as product supply chain, e-commerce streamer resources, and platform traffic.Through the Agreement, the...

COPENHAGEN, Denmark, Nov. 25, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that the company will participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 3, 2020. Company executives will provide a business overview and update on the company’s pipeline programs.DetailsA live webcast of the presentation will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the events for 30 days.About Ascendis Pharma A/S Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated...

OCALA, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced developments in its work to develop new treatments or preventive strategies for COVID-19, the disease caused by SARS-CoV-2.First, AIM reports that Roswell Park Comprehensive Cancer Center’s Phase 1/2a study evaluating the two-drug combination of AIM’s Ampligen and interferon alpha-2b as a potential early-onset treatment for patients with cancer and mild-to-moderate COVID-19 is fully underway, with the first patient enrolled and treated on the study.AIM is a collaborator on that clinical trial, which is funded in part through grants from the National Cancer Institute and AIM, as well as institutional support from Roswell Park. AIM is providing Ampligen at no charge for this study. Full details about this trial, which is led by Roswell...

Hluthafafundur Sjóvá-Almennra trygginga hf. var haldinn kl. 10:00 þann 25. nóvember 2020. Fundurinn var haldinn í fundarsölum F og G á Hilton Reykjavík Nordica að Suðurlandsbraut 2, Reykjavík, auk þess að vera sendur út rafrænt.Eftirfarandi eru niðurstöður fundarins:      1.       Ákvörðun um tillögu stjórnar um greiðslu arðs og meðferð hagnaðar á síðastliðnu reikningsáriTillaga stjórnar um að ekki verði greiddur út arður vegna rekstrarársins 2019 og að hagnaður ársins 2019 komi til hækkunar á eigin fé félagsins var samþykkt.      2.       Önnur mál löglega fram borinEngin önnur mál voru tekin fyrir á fundinum.

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) är glada över att kunna presentera uppmuntrande resultat från bolagets utvidgnings- och definitionsborrningsprogram i Aurora-zonen i Björkdal-gruvan. Dessa resultat markerar den öppna karaktären för de djupgående utvidgningarna och en ny framträdande domän av höghaltig malm.Viktiga punkter avseende borrning vid AuroraUtvidgningsborrning österut och nedåt på djupet:4,8 g/t guld över en sann bredd på 2,47 m i MU20-007; och2,7 g/t guld över en sann bredd på 2,82 m i MU20-016Definitionsborrning österut:8,1 g/t guld över en sann bredd på 2,99 m i DOD2020-063; och3,0 g/t guld över en sann bredd på 3,45 m i DOD2020-073Viktiga punkter i omgivande ådror:14,5 g/t guld över en sann bredd på 2,92 m i DOD2020-060; och38,7 g/t...

Selskabsmeddelelse nr. 14 / 2020

AS Merko Ehitus Eesti, part of AS Merko Ehitus group, has launched the fifth and final stage of Pikaliiva residential development project in Tallinn. The new stage includes two buildings with 66 apartments, which are to be completed by the end of 2021.New residential buildings will be located at Äkke 5 and Äkke 7. The size of the apartments ranges between 34–84 square metres and the price per square metre starts from 2,100 euros. The buildings have energy class B rating. Parking spaces will be built around the houses, greenery and children’s playground will be created in the interior courtyards.Pikaliiva residential quarter (merko.ee/pikaliiva) is located in Tallinn Haabersti District close to Lake Harku. The development project comprises in total of 298 new homes in ten four-storeyed residential buildings, of which six are completed...